Enhancing TIL trafficking via paired cell engineering and lipid nanoparticle modulation of the tumor microenvironment in mucosal melanoma

Active Project Grant Awarded Last action

Award ID
HT9425261E361
Recipient
Awarding agency
Obligated
$140,000

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date 18% complete
Place of performance
Irwindale, CA 91010, USA

Award details come from USAspending.gov.

About this award

Written by GovTribe AI ·

The Defense Health Agency awarded Beckman Research Institute of The City of Hope $140,000 on September 1, 2026, under the Military Medical Research and Development program (CFDA 12.420) to enhance tumor-infiltrating lymphocyte (TIL) trafficking via paired cell engineering and lipid nanoparticle modulation of the tumor microenvironment in mucosal melanoma. The award period runs through August 31, 2027, with work performed at Beckman's facility in Irwindale, California. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform health care for Service Members and the American public through innovative medical solutions, with typical award periods of three to four years and funding ranges from $100,000 to $20 million depending on sub-program priorities and project scope.

Quick answers

Who received award HT9425261E361?

HT9425261E361 was awarded to Beckman Research Institute Of The City Of Hope by Defense Health Agency (Department of Defense) on September 1, 2026.

How much is award HT9425261E361 worth?

$140,000 has been obligated on HT9425261E361.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login